首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Esmo open

缩写:

ISSN:N/A

e-ISSN:2059-7029

IF/分区:8.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2013
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
S C Yazgan,E Yekedüz,E Akkuş et al. S C Yazgan et al.
Background: Poly (ADP-ribose) polymerase inhibitors (PARPi) are linked to thrombotic events, but the thrombosis risk in various cancers is unclear. This study evaluates the incidence and risk of venous thromboembolic even...
J Zhou,M S Wibawa,R Wang et al. J Zhou et al.
Background: The TNM (tumour-node-metastasis) staging system is the primary tool for treatment decisions in nasopharyngeal carcinoma (NPC). However, therapeutic outcomes vary considerably between patients, and guidelines f...
V Seguí,J A Carbonell-Asins,J Martín-Arana et al. V Seguí et al.
Background: The wide use of high-throughput technologies has facilitated the rise of precision medicine. The European Society for Medical Oncology (ESMO) Scale for Clinical Actionability of molecular Targets (ESCAT) guide...
B Walbaum,O Martínez-Sáez,F Brasó-Maristany et al. B Walbaum et al.
Background: Young women (≤40 years at diagnosis) with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (EBC) represent a high-risk group with distinct biologic...
Q Rao,H Zhou,W Weng et al. Q Rao et al.
Background: Endometrial cancer (EC) is among the most prevalent gynecological malignancies worldwide. This study explores the use of cell-free DNA (cfDNA) fragmentomics to develop a non-invasive liquid biopsy assay, aimin...
T Hofmarcher,A Charalambous,N Normanno et al. T Hofmarcher et al.
Background: An increasing number of cancer medicines are being developed and approved. Access to these medicines is important for improving patient outcomes and overall quality of care, yet achieving equitable access acro...
S Hwang,M H Hong,S H Shin et al. S Hwang et al.
Background: Recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) is associated with a poor prognosis. Limited treatment options highlight the need for precision therapeutics. ...